In contrast, in HCC, FOLR2+ macrophages exhibited a fetal-like reprogramming that enhanced the immune-suppressive state in tumor tissues, similar to the immune characteristics observed during liver development (Sharma et al., 2020). The gene discussed is FOLR2; the disease is hepatocellular carcinoma.